European Journal of Endocrinology · 2015 · 22 citations · 11 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyEndocrine OncologyCancer DiagnosisComputed TomographyPositron Emission TomographyRecurrence MonitoringTumor DetectionTumor ImagingAdrenal Carcinoma EvaluationAdrenal Carcinoma ImagingAdrenal Tumor DiagnosisAdrenalectomy For Adrenocortical CarcinomaComparative Diagnostic PerformancePositron Emission Tomography DetectionRecurrenceRecurrence Of Adrenal Tumors
CONTEXT: The role of (18)F-labeled 2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in the post-operative monitoring of patients with adrenocortical carcinoma (ACC) is still unclear. OBJECTIVE: To assess the accuracy of FDG PET/CT to diagnose ACC recurrence in a real world setting. DESIGN AND METHODS: Retrospective evaluation of data of 57 patients with presumed ACC recurrence at CT scan who underwent FDG PET/CT within a median time of 20 days. We compared the results of either FDG PET/CT or CT with a gold standard confirmation of recurrence (positive histopathology report of removed/biopsied lesions or radiological progression of target lesions at follow-up) to assess their diagnostic performance at different body sites to correctly categorize target lesions. We also assessed whether FDG PET/CT findings may be useful to inform the management strategy. RESULTS: In 48 patients with confirmed ACC recurrence, we found that FDG PET/CT had lower sensitivity than CT in diagnosing liver and lung recurrences of ACC. FDG PET/CT had higher specificity than CT in categorizing liver lesions. FDG PET/CT had a greater positive likelihood ratio than CT to identify liver and abdominal ACC recurrences. The management strategy was changed based on FDG PET/CT findings in 12 patients (21.1%). CONCLUSIONS: The greater sensitivity of CT may be partly expected due the specific inclusion criteria of the study; however, the greater specificity of FDG PET/CT was particularly useful in ruling out suspected ACC recurrences found by CT. Thus, use of FDG PET/CT as a second-line test in the post-operative surveillance of ACC patients following CT finding of a potential recurrence may have a significant impact on patient management.
11
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Alfredo Berruti, Eric Baudin, Hans Gelderblom et al. · Annals of Oncology · 2012 · 330 citations · Full text
Accuracy of PET/CT in characterization of solitary pulmonary lesions.
Shanna K Kim, Martin Allen-Auerbach, Jonathan Goldin et al. · PubMed · 2007 · 268 citations